Milrinone vs Dobutamine for the Management of Cardiogenic Shock: Implications of Renal Function and Injury.
Di Santo P, Dehghan K, Mao B, Jung RG, Fadare D, Paydar J, Parlow S, Motazedian P, Prosperi-Porta G, Abdel-Razek O, Joseph J, Goh CY, Chung K, Mulloy A, Ramirez FD, Simard T, Hibbert B, Mathew R, Russo JJ.
Di Santo P, et al.
JACC Adv. 2023 Jul 5;2(5):100393. doi: 10.1016/j.jacadv.2023.100393. eCollection 2023 Jul.
JACC Adv. 2023.
PMID: 38938997
Free PMC article.
METHODS: In this post hoc analysis of the DOREMI (Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock) trial, we examined clinical outcomes with milrinone compared to dobutamine after stratification based on baseline estimated glomerular filtration rate (e …
METHODS: In this post hoc analysis of the DOREMI (Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock) trial, we exa …